DEXCOM INC (DXCM)
DEXCOM INC (DXCM) from its SEC filings: 2025 revenue $4.7 billion (+16% vs the year before), net margin 18%, free cash flow $1.1 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $4.7 billion |
| Revenue growth | +16% |
| Net income | $836.3 million |
| Net margin | 17.9% |
| Free cash flow | $1.1 billion |
| Diluted EPS | $2.09 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +13% |
| Cash | $1.1 billion |
| Long-term debt | $2.9 million |
| Share count, 1 year | -4% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.